Merck: Diversified Pipeline and Growth Drivers

Rob Davis (Merck) reviews strong quarter, $70B commercial opportunity, and multiple phase‑three programs.

Play episode from 36:43

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!